PuSH - Publication Server of Helmholtz Zentrum München

Role of hyperthermia in medical oncology.

Onkologe 16, 1063-1071 (2010)
DOI
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
The hallmarks of hyperthermia and its pleotropic effects are in favour of its combined use with chemotherapy. Preclinical research reveals that for heat killing and synergistic effects the thermal dose is most critical. Thermal enhancement of drug cytotoxicity is accompanied by cellular death and necrosis. Hereby, temperature application rate as well as sequence and time interval are important for both in vitro and in vivo thermal sensitizations of tumour cells. The positive results of phase II/III trials have definitely established hyperthermia in combination with chemotherapy as a novel clinical modality for the treatment of cancer. Hyperthermia targets the action of chemotherapy within the heated tumour. In specific clinical settings hyperthermia has proven its value and deserves a greater focus and investigation in other malignancies. To further define the role of hyperthermia in multimodal treatment, tumour patients should be included into randomized trials.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.157
0.070
2
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Hyperthermia; Soft tissue sarcoma; Cervical cancer; Pancreatic cancer; Bladder cancer
Language english
Publication Year 2010
HGF-reported in Year 2010
ISSN (print) / ISBN 0947-8965
e-ISSN 1433-0415
Journal Onkologe, Der
Quellenangaben Volume: 16, Issue: 11, Pages: 1063-1071 Article Number: , Supplement: ,
Publisher Springer
Reviewing status Peer reviewed
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-521100-001
Scopus ID 78751677591
Erfassungsdatum 2010-12-31